Predict your next investment

HEALTHCARE | Biotechnology
humacyte.com

See what CB Insights has to offer

Business Relationships

4

Service Providers

1

Humacyte Service Providers

1 Service Provider

Humacyte has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Reverse Merger

Counsel

General Counsel

Service Provider

Associated Rounds

Reverse Merger

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Humacyte Partners & Customers

4 Partners and customers

Humacyte has 4 strategic partners and customers. Humacyte recently partnered with Fresenius Medical Care on June 6, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

6/11/2018

Partner

Fresenius Medical Care

Germany

Fresenius Medical Care’s $150 Million Global Partnership with Humacyte

Fresenius Medical Care , the world 's largest provider of dialysis products and services , and Humacyte , Inc. , a medical research , discovery and development company , today announced a strategic , global partnership and a $ 150M USD equity investment .

10

10/2/2017

Client

U.S. Department of Defense

United States

Subscribe to see more

Subscribe to see more

10

5/23/2016

Partner

Allosource

United States

Subscribe to see more

Subscribe to see more

10

10/11/2013

Partner

Allosource

United States

Subscribe to see more

Subscribe to see more

10

Date

6/11/2018

10/2/2017

5/23/2016

10/11/2013

Type

Partner

Client

Partner

Partner

Business Partner

Fresenius Medical Care

U.S. Department of Defense

Allosource

Allosource

Country

Germany

United States

United States

United States

News Snippet

Fresenius Medical Care’s $150 Million Global Partnership with Humacyte

Fresenius Medical Care , the world 's largest provider of dialysis products and services , and Humacyte , Inc. , a medical research , discovery and development company , today announced a strategic , global partnership and a $ 150M USD equity investment .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.